Literature DB >> 25863675

Effect of posterior vitreous detachment on aqueous humor level of vascular endothelial growth factor in exudative age-related macular degeneration patients.

Yoko Nomura1, Hidenori Takahashi2,3, Xue Tan2, Yujiro Fujino4, Hidetoshi Kawashima3, Yasuo Yanagi5.   

Abstract

BACKGROUND: To investigate the association of posterior vitreous detachment (PVD) with aqueous levels of vascular endothelial growth factor (VEGF) in eyes with exudative age-related macular degeneration (AMD).
METHODS: This is a prospective comparative study. Subjects are 33 eyes with exudative AMD. PVD was examined by B-mode ultrasonography and the subjects were divided into a complete PVD group (PVD group) or a group with partial or no PVD (without PVD group). At the beginning of intravitreal injection of ranibizumab, aqueous humor was collected and the concentration of VEGF was measured using ELISA. The concentration was compared between the two groups.
RESULTS: Complete PVD was observed in 13 (39 %) eyes. The mean concentration of VEGF was 58 pg/ml in the PVD group and 91 pg/ml in the without PVD group. Multiple regression analysis revealed that the concentration of VEGF was significantly lower in the eyes with PVD than in those without PVD independent of age and sex (P = 0.02).
CONCLUSIONS: Complete PVD is related to the lower concentration of aqueous VEDF in AMD eyes.

Entities:  

Keywords:  Age-related macular degeneration; Aqueous humor; Posterior vitreous detachment; Vascular endothelial growth factor

Mesh:

Substances:

Year:  2015        PMID: 25863675     DOI: 10.1007/s00417-015-3006-2

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  24 in total

1.  Pharmacologic vitreolysis with microplasmin increases vitreous diffusion coefficients.

Authors:  J Sebag; Rafat R Ansari; Kwang I Suh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-08-29       Impact factor: 3.117

2.  Vitreomacular interface in typical exudative age-related macular degeneration and polypoidal choroidal vasculopathy.

Authors:  Yoko Nomura; Takashi Ueta; Aya Iriyama; Yuji Inoue; Ryo Obata; Yasuhiro Tamaki; Takuhiro Yamaguchi; Yasuo Yanagi
Journal:  Ophthalmology       Date:  2010-11-20       Impact factor: 12.079

3.  Vitreomacular adhesion in active and end-stage age-related macular degeneration.

Authors:  Craig D Robison; Ilse Krebs; Susanne Binder; Irene A Barbazetto; Athanasios I Kotsolis; Lawrence A Yannuzzi; Alfredo A Sadun; Jerry Sebag
Journal:  Am J Ophthalmol       Date:  2009-03-27       Impact factor: 5.258

4.  Effects of vitreomacular adhesion on ranibizumab treatment in Japanese patients with age-related macular degeneration.

Authors:  Yoko Nomura; Hidenori Takahashi; Xue Tan; Shigeto Fujimura; Ryo Obata; Yasuo Yanagi
Journal:  Jpn J Ophthalmol       Date:  2014-08-06       Impact factor: 2.447

5.  Role of the vitreous in age-related macular degeneration.

Authors:  F Ondeş; G Yilmaz; M A Acar; N Unlü; H Kocaoğlan; A K Arsan
Journal:  Jpn J Ophthalmol       Date:  2000 Jan-Feb       Impact factor: 2.447

6.  Aqueous humor levels of vasoactive molecules correlate with vitreous levels and macular edema in central retinal vein occlusion.

Authors:  Hidetaka Noma; Hideharu Funatsu; Tatsuya Mimura; Seiyo Harino; Sadao Hori
Journal:  Eur J Ophthalmol       Date:  2010 Mar-Apr       Impact factor: 2.597

Review 7.  Vitreomacular adhesion and neovascular age-related macular degeneration.

Authors:  Andrew R H Simpson; Robert Petrarca; Timothy L Jackson
Journal:  Surv Ophthalmol       Date:  2012-11       Impact factor: 6.048

8.  Influence of the vitreomacular interface on outcomes of ranibizumab therapy in neovascular age-related macular degeneration.

Authors:  Ulrike Mayr-Sponer; Sebastian M Waldstein; Michael Kundi; Markus Ritter; Isabelle Golbaz; Ursula Heiling; Andrea Papp; Christian Simader; Ursula Schmidt-Erfurth
Journal:  Ophthalmology       Date:  2013-07-16       Impact factor: 12.079

9.  Anomalous vitreoretinal adhesions in patients with exudative age-related macular degeneration: an OCT study.

Authors:  M Quaranta-El Maftouhi; M Mauget-Faÿsse
Journal:  Eur J Ophthalmol       Date:  2006 Jan-Feb       Impact factor: 2.597

10.  Microplasmin-induced posterior vitreous detachment affects vitreous oxygen levels.

Authors:  Polly A Quiram; Victor R Leverenz; Robert M Baker; Loan Dang; Frauk J Giblin; Michael T Trese
Journal:  Retina       Date:  2007-10       Impact factor: 4.256

View more
  4 in total

1.  The effects of vitreous on proliferative diabetic retinopathy and the response to pan retinal photocoagulation.

Authors:  J Sebag; Jeannie Nguyen-Cuu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-10-22       Impact factor: 3.117

Review 2.  Vitreous anatomy and the vitreomacular correlation.

Authors:  Shoji Kishi
Journal:  Jpn J Ophthalmol       Date:  2016-05-10       Impact factor: 2.447

Review 3.  Characteristics of Pachychoroid Diseases and Age-Related Macular Degeneration: Multimodal Imaging and Genetic Backgrounds.

Authors:  Kenji Yamashiro; Yoshikatsu Hosoda; Masahiro Miyake; Sotaro Ooto; Akitaka Tsujikawa
Journal:  J Clin Med       Date:  2020-06-29       Impact factor: 4.241

4.  Influence of vitreomacular interface score on treatment outcomes of anti-VEGF therapy for neovascular age-related macular degeneration.

Authors:  Manabu Miyata; Sotaro Ooto; Kenji Yamashiro; Hiroshi Tamura; Akihito Uji; Masahiro Miyake; Yuki Muraoka; Ayako Takahashi; Akitaka Tsujikawa
Journal:  Int J Retina Vitreous       Date:  2021-12-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.